Orano

(IN BRIEF) Orano has been chosen by the US Department of Energy to receive up to 900 million US dollars in funding to support the construction of a new uranium enrichment facility in the United States, representing a total investment … Read the full press release →

(IN BRIEF) Orano welcomed a European Investment Bank delegation to its Tricastin site in southern France to review progress on the €1.7 billion expansion of the Georges Besse 2 enrichment plant, backed by the EIB’s €400 million financing commitment from … Read the full press release →

(IN BRIEF) Orano announced the launch of serial production of the 30B-10 cylinders at the World Nuclear Supply Chain (WNSC) symposium in Warsaw, designed to transport Low Enriched Uranium Plus (LEU+) enriched up to 10%. The new DN30-X package, which … Read the full press release →

(IN BRIEF) Orano and Navoiyuran have formalized an agreement to advance the South Djengeldi uranium mining project within their joint venture, Nurlikum Mining, by integrating it into Navoiyuran’s existing industrial base. The deal also brings Japan’s ITOCHU Corporation on board … Read the full press release →

(IN BRIEF) Orano has signed the “Working with Cancer” pledge, joining a global initiative led by Publicis Chair and CEO Arthur Sadoun to promote cancer prevention and support employees affected by cancer. The pledge reflects Orano’s commitment to employee well-being … Read the full press release →

(IN BRIEF) Sanofi and Orano Med have partnered to accelerate the development of next-generation radioligand therapies (RLTs) for rare cancers. By combining their expertise, they aim to advance treatments using lead-212 (212Pb) alpha-emitting isotopes, which target and destroy cancer cells … Read the full press release →

(IN BRIEF) Orano, a responsible mining company with a 25-year presence in Mongolia, has signed a protocol for the development and operation of the Zuuvch-Ovoo uranium mine project in Mongolia. The signing ceremony took place at the Elysée Palace in … Read the full press release →

(IN BRIEF) Orano Med, a subsidiary of Orano specialized in nuclear medicine, was awarded the Biotech Prize at the “Trophées de la HealthTech” event. The company is developing a new generation of targeted therapies for cancer using the unique properties … Read the full press release →